Business Standard

Lasa Supergenerics standalone net profit rises 223.16% in the March 2022 quarter

Image

Capital Market

Sales rise 30.97% to Rs 51.21 crore

Net profit of Lasa Supergenerics rose 223.16% to Rs 12.28 crore in the quarter ended March 2022 as against Rs 3.80 crore during the previous quarter ended March 2021. Sales rose 30.97% to Rs 51.21 crore in the quarter ended March 2022 as against Rs 39.10 crore during the previous quarter ended March 2021.

For the full year,net loss reported to Rs 5.37 crore in the year ended March 2022 as against net profit of Rs 22.78 crore during the previous year ended March 2021. Sales declined 32.24% to Rs 137.13 crore in the year ended March 2022 as against Rs 202.38 crore during the previous year ended March 2021.

 
ParticularsQuarter EndedYear EndedMar. 2022Mar. 2021% Var.Mar. 2022Mar. 2021% Var.Sales51.2139.10 31 137.13202.38 -32 OPM %21.3423.25 -11.4023.33 - PBDT10.939.06 21 15.6545.32 -65 PBT7.455.12 46 1.6529.50 -94 NP12.283.80 223 -5.3722.78 PL

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Apr 11 2022 | 3:36 PM IST

Explore News